FR2584405B1 - Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation - Google Patents

Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation

Info

Publication number
FR2584405B1
FR2584405B1 FR868609017A FR8609017A FR2584405B1 FR 2584405 B1 FR2584405 B1 FR 2584405B1 FR 868609017 A FR868609017 A FR 868609017A FR 8609017 A FR8609017 A FR 8609017A FR 2584405 B1 FR2584405 B1 FR 2584405B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical composition
composition containing
furosemide
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR868609017A
Other languages
English (en)
Other versions
FR2584405A1 (fr
Inventor
Lester Chafetz
Jose Philip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of FR2584405A1 publication Critical patent/FR2584405A1/fr
Application granted granted Critical
Publication of FR2584405B1 publication Critical patent/FR2584405B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
FR868609017A 1985-07-02 1986-06-23 Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation Expired FR2584405B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (2)

Publication Number Publication Date
FR2584405A1 FR2584405A1 (fr) 1987-01-09
FR2584405B1 true FR2584405B1 (fr) 1989-02-24

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868609017A Expired FR2584405B1 (fr) 1985-07-02 1986-06-23 Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation

Country Status (14)

Country Link
US (1) US4663348A (fr)
JP (1) JPS625975A (fr)
AU (1) AU599034B2 (fr)
BE (1) BE904986A (fr)
CH (1) CH670448A5 (fr)
DE (1) DE3619665A1 (fr)
DK (1) DK312586A (fr)
FR (1) FR2584405B1 (fr)
GB (1) GB2189239B (fr)
IT (1) IT1191972B (fr)
LU (1) LU86484A1 (fr)
NL (1) NL8601519A (fr)
SE (1) SE8602917L (fr)
ZA (1) ZA864207B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
US5330280A (en) * 1991-12-03 1994-07-19 Kokuyo Kabushiki Kaisha Filing apparatus of both-side opening/closing type
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2557237C2 (ru) 2010-02-10 2015-07-20 Киссеи Фармасьютикал Ко., Лтд. Соль конденсированного гетероциклического производного и его кристаллы
JP6415535B2 (ja) * 2013-04-05 2018-10-31 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下投与用の医薬製剤
EP3906019A1 (fr) 2019-01-04 2021-11-10 SQ Innovation AG Compositions pharmaceutiques de furosémide et leurs utilisations
EP3917495A1 (fr) 2019-01-31 2021-12-08 scPharmaceuticals Inc. Formulations pharmaceutiques liquides concentrées de furosémide et leurs méthodes d'administration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (fr) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
SE8602917L (sv) 1987-01-03
US4663348A (en) 1987-05-05
LU86484A1 (fr) 1986-12-02
GB8615275D0 (en) 1986-07-30
DK312586D0 (da) 1986-07-01
DK312586A (da) 1987-01-03
ZA864207B (en) 1987-02-25
CH670448A5 (fr) 1989-06-15
IT1191972B (it) 1988-03-31
NL8601519A (nl) 1987-02-02
AU599034B2 (en) 1990-07-12
DE3619665A1 (de) 1987-01-08
FR2584405A1 (fr) 1987-01-09
JPS625975A (ja) 1987-01-12
IT8648183A0 (it) 1986-06-25
BE904986A (fr) 1986-12-24
AU5889086A (en) 1987-01-08
GB2189239A (en) 1987-10-21
GB2189239B (en) 1989-02-01
SE8602917D0 (sv) 1986-07-01

Similar Documents

Publication Publication Date Title
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
PT81310B (fr) Procede de preparation de derives de piperidine et de compositions pharmaceutiques les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2510572B1 (fr) Nouvelles thiazolidinediones, leur procede de production et preparation pharmaceutique les contenant
PT83896A (fr) Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant
FR2584405B1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
FR2522324B1 (fr) Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
FR2581385B1 (fr) Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2582835B1 (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2586681B1 (fr) Derives du methylene-dioxy-phenanthrene et du stilbene, procede pour leur preparation et medicaments les contenant
BE890874A (fr) Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
MC1549A1 (fr) Anthracycline-glycosides,procede pour leur preparation et medicaments les contenant
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
BE889990A (fr) Nouveaux composes cytostatiques, leur procede de preparation et composition pharmaceutique les contenant
FR2517672B1 (fr) Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse